NextCell Pharma AB (STO:NXTCL)

NextCell Pharma AB Revenue

NextCell Pharma AB had revenue of 2.78M SEK in the quarter ending March 31, 2026, with 85.53% growth. This brings the company's revenue in the last twelve months to 10.61M, up 0.59% year-over-year. In the year 2025, NextCell Pharma AB had annual revenue of 13.96M with 26.17% growth.

• Revenue (ttm): 10.61M
• Revenue Growth: +0.59%
• P/S Ratio: 13.81
• Revenue / Employee: 385.14K
• Employees: 24
• Market Cap: 127.66M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	13.96M	2.90M	26.17%
Aug 31, 2025	11.06M	-213.70K	-1.89%
Dec 31, 2024	11.28M	-	-
Aug 31, 2024	11.28M	-2.68M	-19.18%
Aug 31, 2023	13.96M	7.73M	124.03%
Aug 31, 2022	6.23M	1.78M	39.85%
Aug 31, 2021	4.45M	287.92K	6.91%
Aug 31, 2020	4.17M	2.20M	112.11%
Aug 31, 2019	1.96M	1.31M	199.68%
Aug 31, 2018	655.41K	138.21K	26.72%
Aug 31, 2017	517.20K	-	-
Aug 31, 2016	-	-	-

Data Source: Fiscal.ai Last updated: May 28, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 19, 2026

Data Sources Report a data error